Fundraising FoxAlexandria — 2016 Investments
3 investments dated 2016 · listed companies and verified rows first · show all
Codiakbiocodiakbio.comJan 2016
Cambridge, MA clinical-stage biotech developing engineered exosome therapeutics; IPO'd on NASDAQ in 2020, later restructured.
BiotechSeattle, US
Doug Williams(Executive Officer, Director)in
BoardNoubar Afeyan(Director)inSteven Gillis(Director)Eric Lander(Director)
Co-investorsARCH Venture PartnersEcoR1 CapitalFidelity InvestmentsFlagship PioneeringQatar Investment Authority
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.